v3 Template
O

OncoResponse

Biotechnology / Healthcare ~10 employees
Founded
--
Employees (Est.)
~10
1 leaders known
Total Funding
$14.0M
Funding Rounds
1
Last Funding
2023-05-18

About OncoResponse

OncoResponse is a biotech company focused on discovering and developing novel cancer immunotherapies by leveraging the human immune system, particularly through the immune responses of 'Elite Cancer Responders.' Their mission is to attack cancer by making 'cold' tumors 'hot' using a clinically validated technology platform to relieve immunosuppression in the tumor microenvironment.

Products & Services

Technology Platform:A clinically validated platform to discover authentic human antibodies targeting immunosuppressive myeloid biology.
Pipeline of Monoclonal Antibodies:A preclinical pipeline focused on removing brakes on immune cells in the tumor microenvironment to enhance immune activity.

Specialties

Cancer Immunotherapy Immuno-Oncology Monoclonal Antibodies Tumor Microenvironment Immunomodulatory Antibodies

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Venture Capital
T: -
FT: Venture Capital 		A: 14000000
MR: -
FA: 14 million
FAN: 14000000 		D: 2023-05-18
FD: 2023-05-18 		7 investors
Venture Capital Latest
2023-05-18
$14.0M
7 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

S

Sally Church

Recent News

OncoResponse Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~10 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro